Last updated on December 2019

A Study to Assess the Efficacy Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy


Brief description of study

The purpose of the study is to evaluate clinical efficacy of rozanolixizumab as a treatment for subjects with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

Clinical Study Identifier: NCT03861481

Find a site near you

Start Over

Cidp01 403

Marseille, France
  Connect »